Expert Lists Data Integrity Red Flags for Drug Sponsors

Drug Industry Daily
Drug sponsors should ask themselves three data integrity questions before the FDA can, according to John Avellanet, managing director and principal consultant at Cerulean Associates, during an expert panel at the RAPS’ 2017 Regulatory Convergence meeting.

To View This Article:


Subscribe To Drug Industry Daily